These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7395601)

  • 1. Opioid agonists and antagonists in schizophrenia.
    Barchas JD; Berger PA; Watson SJ; Akil H; Li CH
    Adv Biochem Psychopharmacol; 1980; 22():447-53. PubMed ID: 7395601
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of narcotics and narcotic antagonists on affective disorders, schizophrenia and serum neurohormones.
    Judd LL; Janowsky DS
    Mod Probl Pharmacopsychiatry; 1981; 17():213-25. PubMed ID: 6120452
    [No Abstract]   [Full Text] [Related]  

  • 3. [Etiologic and therapeutic significance of endorphins in endogenous psychoses].
    Naber D
    Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
    Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
    Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endorphins in psychiatry].
    Lajeunesse C; Villeneuve A
    Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051
    [No Abstract]   [Full Text] [Related]  

  • 6. Research in endorphins and schizophrenia.
    Davis GC; Buchsbaum MS; Bunney WE
    Schizophr Bull; 1979; 5(2):244-50. PubMed ID: 37596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Administration of naloxone in schizophrenic psychoses and manic syndromes].
    Verhoeven WM; van Praag HM; de Jong JT
    Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral effects of opioid receptor antagonists in psychopathologic states.
    Janowsky DS; Judd LL; Huey LY; Risch SC; Segal DS
    Psychiatr Clin North Am; 1983 Sep; 6(3):403-14. PubMed ID: 6316300
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of naloxone in schizophrenic psychoses and manic syndromes.
    Verhoeven WM; van Praag HM; de Jong JT
    Neuropsychobiology; 1981; 7(3):159-68. PubMed ID: 7231653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
    Kurland AA; McCabe OL; Hanlon TE; Sullivan D
    Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies on the role of endorphins in schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiates, opioid peptides and psychiatry.
    Davis GC; Buchsbaum MS; Bunney WE
    Ann N Y Acad Sci; 1981; 362():67-75. PubMed ID: 7020533
    [No Abstract]   [Full Text] [Related]  

  • 15. Endorphins in psychiatry: an overview and a hypothesis.
    Verebey K; Volavka J; Clouet D
    Arch Gen Psychiatry; 1978 Jul; 35(7):877-88. PubMed ID: 209757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endogenous opioids and gamma type endorphins in schizophrenia].
    Verhoeven WM
    Arch Neurobiol (Madr); 1983; 46(5):335-8. PubMed ID: 6362599
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of effect of naloxone and schizophrenic auditory hallucinations.
    Freeman CP; Fairburn CG
    Psychol Med; 1981 May; 11(2):405-7. PubMed ID: 7022531
    [No Abstract]   [Full Text] [Related]  

  • 18. [New perspectives in the treatment of shock. Use of naloxone].
    González-Esparza L
    Rev Med Univ Navarra; 1982 Mar; 26(1):55-8. PubMed ID: 7111954
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigating opioid peptides in schizophrenia and depression.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():309-33. PubMed ID: 2941840
    [No Abstract]   [Full Text] [Related]  

  • 20. Naloxone in schizophrenia.
    Skrabanek P
    Lancet; 1982 Dec; 2(8310):1270. PubMed ID: 6128561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.